Dexoxadrol
From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by Dcirovic (talk | contribs) at 18:50, 29 May 2016 (clean up using AWB). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C20H23NO2 |
Molar mass | 309.40 g/mol g·mol−1 |
3D model (JSmol) | |
| |
| |
NY (what is this?) (verify) |
Dexoxadrol (Dioxadrol) is a dissociative anaesthetic drug which has been found to be an NMDA antagonist and produces similar effects to PCP in animals. Dexoxadrol, along with another related drug etoxadrol, were developed as analgesics for use in humans, but development was discontinued after patients reported side effects such as nightmares and hallucinations.[1][2]
See also
References
- ^ Sax, M.; Wünsch, B. (2006). "Relationships between the structure of dexoxadrol and etoxadrol analogues and their NMDA receptor affinity". Current Topics in Medicinal Chemistry. 6 (7): 723–732. doi:10.2174/156802606776894483. PMID 16719812.
- ^ Aepkers, M.; Wünsch, B. (2005). "Structure-affinity relationship studies of non-competitive NMDA receptor antagonists derived from dexoxadrol and etoxadrol". Bioorganic and Medicinal Chemistry. 13 (24): 6836–6849. doi:10.1016/j.bmc.2005.07.030. PMID 16169732.
|
This hallucinogen-related article is a stub. You can help Wikipedia by expanding it. |
Hidden categories:
- Drugs with non-standard legal status
- Articles with changed CASNo identifier
- Chem-molar-mass both hardcoded and calculated
- Infobox-drug molecular-weight unexpected-character
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugboxes which contain changes to verified fields
- All stub articles